ENTRY       D12561                      Drug
NAME        Enristomig (USAN)
FORMULA     C4520H7008N1244O1384S30
EXACT_MASS  101818.7858
MOL_WEIGHT  101881.4619
SEQUENCE    EVQLLESGGG EVQPGGSLRL SCAASGGIFA IKPISWYRQA PGKQREWVST TTSSGATNYA
            ESVKGRFTIS RDNAKNTLYL QMSSLRAEDT AVYYCNVFEY WGQGTLVTVK PGGSGGSEVQ
            LLESGGGEVQ PGGSLRLSCA ASGFSFSINA MGWYRQAPGK RREFVAAIES GRNTVYAESV
            KGRFTISRDN AKNTVYLQMS SLRAEDTAVY YCGLLKGNRV VSPSVAYWGQ GTLVTVKPGG
            GGDKTHTCPP CPAPGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG
            VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG
            QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD
            GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Dislfide bridge: 22-95, 139-212, 248-248', 251-251', 280-340, 386-444, 22'-95', 139'-212', 280'-340', 386'-444')
  TYPE      Peptide
CLASS       Antineoplastic
             DG02938  Immune checkpoint inhibitor
EFFICACY    Antineoplastic, Immune checkpoint inhibitor, Anti-PD-L1 antibody
  TYPE      Monoclonal antibody, tetravalent sdAb-based
TARGET      PDL1 (CD274) [HSA:29126] [KO:K06745]
BRITE       Drug groups [BR:br08330]
             Antineoplastic
              DG02938  Immune checkpoint inhibitor
               D12561  Enristomig
            Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               Immune checkpoints
                PDL1 (CD274)
                 D12561  Enristomig (USAN)
DBLINKS     CAS: 2539845-73-1
///
